AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 36 filers reported holding AXSOME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,821,000 | +923.0% | 128,000 | +103.2% | 0.02% | +1050.0% |
| Q4 2018 | $178,000 | -41.4% | 63,000 | -28.4% | 0.00% | -33.3% |
| Q3 2018 | $304,000 | +7.8% | 88,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $282,000 | +30.6% | 88,000 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $216,000 | -22.9% | 88,000 | +76.0% | 0.00% | -33.3% |
| Q4 2017 | $280,000 | +0.7% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $278,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |